Evaluation of the AMICUS RBCx System in Sickle Cell Patients

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 7, 2017

Study Completion Date

January 19, 2018

Conditions
Sickle Cell Anemia
Interventions
DEVICE

Amicus Red Cell Exchange in SCD patients

Each patient will be treated with one RBCx procedure using the AMICUS RBCx System

Trial Locations (6)

19104

The Children's Hospital of Philadelphia, Philadelphia

48201

Barbara Ann Karmanos Cancer Institute, Detroit

53226

BloodCenter of Wisconsin, Milwaukee

63110

Washington University, St Louis

75390

University of Texas Southwestern Medical Center, Dallas

85016

Phoenix Children's Hospital, Phoenix

All Listed Sponsors
collaborator

Versiti

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Barbara Ann Karmanos Cancer Institute

OTHER

collaborator

University of Texas

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

Phoenix Children's Hospital

OTHER

lead

Fenwal, Inc.

INDUSTRY

NCT02372877 - Evaluation of the AMICUS RBCx System in Sickle Cell Patients | Biotech Hunter | Biotech Hunter